- ICH GCP
- Rejestr badań klinicznych w USA
- Badanie kliniczne NCT03049397
Enhancing Connections Program in Improving Family Adjustment in Patients With Incurable Cancer
Family Functioning and Bereavement Outcomes Following the Enhancing Connections Program in Palliative Care
Przegląd badań
Status
Warunki
Interwencja / Leczenie
Szczegółowy opis
PRIMARY OBJECTIVES:
I. Test the feasibility of the study protocol in advanced cancer patients and co-parents (recruitment/retention, dosage and fidelity of the intervention; program acceptability of program; and logistics).
II. Evaluate the short-term impact of the program on the diagnosed parents', co-parents' and children's adjustment and family functioning using a within group design (pre- and posttest design).
III. Compare outcomes from the Enhancing Connections Palliative Program with similar outcomes obtained from the completed phase III trial (between group design) for the patients and children outcomes.
IV. Evaluate the longer term impact of the program on the co-parents' and children's adjustment, including bereavement outcomes when appropriate, using a within and across group design (pre- and posttest design).
OUTLINE:
Patients and co-parents participate in the Enhancing Connections program consisting of 5 sessions over 1 hour each in the clinic or over the telephone. Session topics include managing cancer-related emotions when talking to children, developing deep listening skills, initiating difficult cancer-related conversations with children, interpreting a child's behavior, recognizing newly acquired gains from the program, and identifying available resources that can be used after program completion.
After completion of the study, participants are followed-up at 6 months.
Typ studiów
Zapisy (Rzeczywisty)
Faza
- Nie dotyczy
Kontakty i lokalizacje
Lokalizacje studiów
-
-
Washington
-
Seattle, Washington, Stany Zjednoczone, 98109
- Fred Hutch/University of Washington Cancer Consortium
-
-
Kryteria uczestnictwa
Kryteria kwalifikacji
Wiek uprawniający do nauki
Akceptuje zdrowych ochotników
Płeć kwalifikująca się do nauki
Opis
Inclusion Criteria:
PATIENTS
- Ages 25-65 years
- Have a diagnosis of incurable cancer of any type; at any time in the diagnosis as long as they have at least a 4 month life expectancy based on the opinion of the attending physician
- Read and write English among their languages of choice
- Parent must live at least 50% of the time in the home and have a child 5-17 years old living at home who has been told their parent's cancer diagnosis
CO-PARENTS
- Co-parents must reside with the consenting eligible cancer participant (and child) at least 50% of the time and be actively participating in the care of the child
- If a biological parent lives in the home, and is physically well themselves, this person must be the co-parent
- If a biological parent does not live in the home (or has died), the co-parent does not have to be a biological parent; therefore, co-parents may be step-parents, lesbian, gay, bi-sexual or transgender (LGBT) partners, grandparents, aunts, uncles, etc if they otherwise meet eligibility criteria
- He or she can read and write English among their languages of choice and agrees to attend the patient intervention sessions in person or by telephone
CHILDREN
- The patient and co-parent must agree to focus on the same child throughout the study and consent to have the child participate before the child's assent will be sought
- Children aged 5-13 years of age will participate with a waiver of assent
- Children aged 14-17 will assent to participate in the research study by signing a separate assent form
- Children of formal assenting age will be eligible to participate if they can read and write English among their languages of choice
ALL PARTICIPANTS
- Participants must live within 35 miles of the University of Washington, Seattle, WA to receive the in-person version of the intervention
- Parents and co-parents selecting the telephone version of the intervention may live any distance from the University of Washington
Exclusion Criteria:
- Patients will be excluded if they are enrolled in hospice at time of enrollment; however, they will be allowed to continue in the study if they enroll in hospice after beginning the study
- The triad will be ineligible if any member lives in the home less than 50% of the time
- If any member of the triad retracts consent or assent prior to completion of the post-intervention surveys, then all members will be excluded from the study thereafter
- The child will be excluded if he or she has learning challenges as assessed by the patient or co-parent; patients and co-parents will be instructed to consider any formal diagnoses of a learning disability of the presence of an Individual Education Plan (IEP) when making this assessment
Plan studiów
Jak projektuje się badanie?
Szczegóły projektu
- Główny cel: Leczenie podtrzymujące
- Przydział: Nie dotyczy
- Model interwencyjny: Zadanie dla jednej grupy
- Maskowanie: Brak (otwarta etykieta)
Broń i interwencje
Grupa uczestników / Arm |
Interwencja / Leczenie |
|---|---|
|
Eksperymentalny: Supportive Care (Enhancing Connections program)
Patients and co-parents participate in the Enhancing Connections program consisting of 5 sessions over 1 hour each in the clinic or over the telephone.
Session topics include managing cancer-related emotions when talking to children, developing deep listening skills, initiating difficult cancer-related conversations with children, interpreting a child's behavior, recognizing newly acquired gains from the program, and identifying available resources that can be used after program completion.
|
Badania pomocnicze
Complete Enhancing Connections program
|
Co mierzy badanie?
Podstawowe miary wyniku
Miara wyniku |
Opis środka |
Ramy czasowe |
|---|---|---|
|
Feasibility of the Enhancing Connections program in advanced cancer patients and co-parents
Ramy czasowe: Up to 2 years
|
Recruitment and retention of all triads will be monitored.
Dosage and fidelity will be monitored for each intervention session.
Program acceptability (per session, overall, duration of program, interval between intervention sessions) will be assessed from a debriefing interview.
For logistics four areas will be monitored: rate of receipt of mailed materials both to participants and from participants; duration and type (whether telephone or in-person) of intervention sessions; rate of success in scheduling and completing intervention sessions with patient and co-parent; and quality of data on baseline, post-intervention and follow-up measures.
|
Up to 2 years
|
|
Change in adjustment and family functioning
Ramy czasowe: Baseline to 6 months
|
Descriptive statistics (e.g.
means, medians) will be used to describe the Enhancing Connections palliative care population.
Parents', co-parents and children's baseline scores [parent-reported] on standardized questionnaires will be compared with post-intervention and 6 month follow-up scores on the same measures.
|
Baseline to 6 months
|
|
Outcomes from the Enhancing Connections Palliative Program as measured by the Child Behavior Check List
Ramy czasowe: Up to 2 years
|
Linear mixed modeling based on Maximum Likelihood Estimation will be used to test the differences between the Child Behavior Check List results for the Enhancing Connections Palliative Program and the completed phase III trial (EC-R01).
|
Up to 2 years
|
|
Change in adjustment as measured by post-traumatic growth scores
Ramy czasowe: Baseline to 6 months
|
Enhancing Connection Palliative Program parents', co-parents' and children's post-traumatic growth scores will be compared with follow-up (6 month) scores on the same measure.
|
Baseline to 6 months
|
Współpracownicy i badacze
Sponsor
Współpracownicy
Śledczy
- Główny śledczy: Elizabeth Loggers, Fred Hutch/University of Washington Cancer Consortium
Daty zapisu na studia
Główne daty studiów
Rozpoczęcie studiów (Rzeczywisty)
Zakończenie podstawowe (Rzeczywisty)
Ukończenie studiów (Rzeczywisty)
Daty rejestracji na studia
Pierwszy przesłany
Pierwszy przesłany, który spełnia kryteria kontroli jakości
Pierwszy wysłany (Rzeczywisty)
Aktualizacje rekordów badań
Ostatnia wysłana aktualizacja (Rzeczywisty)
Ostatnia przesłana aktualizacja, która spełniała kryteria kontroli jakości
Ostatnia weryfikacja
Więcej informacji
Terminy związane z tym badaniem
Dodatkowe istotne warunki MeSH
Inne numery identyfikacyjne badania
- 9667 (Inny identyfikator: Fred Hutch/University of Washington Cancer Consortium)
- P30CA015704 (Grant/umowa NIH USA)
- NCI-2016-01640 (Identyfikator rejestru: CTRP (Clinical Trial Reporting Program))
- RG9218011 (Inny identyfikator: Fred Hutch/University of Washington Cancer Consortium)
Informacje o lekach i urządzeniach, dokumenty badawcze
Bada produkt leczniczy regulowany przez amerykańską FDA
Bada produkt urządzenia regulowany przez amerykańską FDA
Te informacje zostały pobrane bezpośrednio ze strony internetowej clinicaltrials.gov bez żadnych zmian. Jeśli chcesz zmienić, usunąć lub zaktualizować dane swojego badania, skontaktuj się z register@clinicaltrials.gov. Gdy tylko zmiana zostanie wprowadzona na stronie clinicaltrials.gov, zostanie ona automatycznie zaktualizowana również na naszej stronie internetowej .
Badania kliniczne na Zaawansowany nowotwór złośliwy
-
Fudan UniversityRekrutacyjnyAdvanced HR - pozytywny, HER2 - ujemny rak piersi | Odporne na (neo) adiuwantową terapię hormonalnąChiny
-
Advanced BionicsZakończonyUbytek słuchu od ciężkiego do głębokiego | u dorosłych użytkowników systemu Advanced Bionics HiResolution™ Bionic EarStany Zjednoczone
-
National University Hospital, SingaporeEDDC (Experimental Drug Development Centre), A*STAR Research EntitiesRekrutacyjnyZ MSS/pMMR Advanced, rakiem jajnika opornym na platynęSingapur
-
Extremity MedicalRekrutacyjnyZapalenie kości i stawów | Zapalne zapalenie stawów | Zespół cieśni nadgarstka (CTS) | Posttraumatyczne zapalenie stawów | Scapholunate Advanced Collapse (SLAC) | Zaawansowane załamanie krystaliczne scapholunate (SCAC) | Zaawansowane załamanie kości łódeczkowatej, trapezowej i trapezowej (STTAC) | Choroba... i inne warunkiStany Zjednoczone
Badania kliniczne na Administracja kwestionariuszami
-
Cairn DiagnosticsZakończony
-
Nova Scotia Health AuthorityJeszcze nie rekrutacja
-
Koç UniversityJeszcze nie rekrutacjaJakość życia | Nietrzymanie moczu, popęd | Stres związany z nietrzymaniem moczu
-
University of California, San FranciscoNational Institute of Allergy and Infectious Diseases (NIAID); GlaxoSmithKline; Stanford University i inni współpracownicyRekrutacyjnyMalaria | Malaria Plasmodium VivaxPeru
-
University of North Carolina, Chapel HillNational Institute of Allergy and Infectious Diseases (NIAID)Jeszcze nie rekrutacjaZapobieganie malariiUganda
-
Peking University Third HospitalJeszcze nie rekrutacjaOsteoporoza | Zaburzenia rytmu okołodobowego
-
Pyae Linn AungUniversity of South Florida; Mahidol UniversityAktywny, nie rekrutującyMalaria | Plasmodium Vivax | Myanmar | Masowa Administracja Leków | PrymachinaMyanmar
-
Assistance Publique - Hôpitaux de ParisURC-CIC Paris Descartes Necker CochinRekrutacyjnyWrodzone wady rozwojowe płucFrancja
-
Montreal Heart InstituteZakończony
-
Washington University School of MedicineZakończonyFilarioza limfatyczna | Onchocerkoza | Zakażenia robakami przenoszonymi przez glebę (STH).Liberia